Luo Z

No ORCID on file · 29 papers in corpus · active 2013-2026

Study types

  • article 3
  • other 3
  • preprint 3
  • review 2

Condition tags

  • endometriosis 5
  • adenomyosis 4
  • dysmenorrhea 3
  • infertility 1
2016
Epigenetic repression of PDZ-LIM domain-containing protein 2 promotes ovarian cancer via NOS2-derived nitric oxide signaling.
Oncotarget ·doi:10.18632/oncotarget.6368

Ovarian cancer constitutes one of the most lethal gynaecological malignancies worldwide and currently no satisfactory therapeutic approaches have been established. Therefore, elucidation of molecular mechanisms to develop targeted therapy o…

review 2015
A mass spectrometric insight into the origins of benign gynecological disorders
Mass spectrometry reviews ·doi:10.1002/mas.21484

Applications of mass spectrometry (MS) are rapidly expanding and encompass molecular and cellular biology. MS aids in the analysis of in vivo global molecular alterations, identifying potential biomarkers which may improve diagnosis and tre…

article 2014
Increased expression of fibroblast growth factor receptor 1 in endometriosis and its correlation with endometriosis-related dysmenorrhea and recurrence
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2014.11.013

Objective(s)This study aims to identify a critical molecule that potentially participates in endometriosis pathogenesis and characterize its correlation with dysmenorrhea and recurrence.Study designWe utilized a bioinformatics-based strateg…

2013
Clinical value of serum human epididymis protein 4 assay in the diagnosis of ovarian cancer: a meta-analysis.
OncoTargets and therapy ·doi:10.2147/ott.s45681

ObjectiveHuman epididymis protein 4 (HE4) has been approved for diagnosing ovarian cancer. The goal of this meta-analysis was to evaluate the clinical value of the serum HE4 in the diagnosis of ovarian cancer.MethodsThe PubMed and Embase da…